English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
 Local TagsRelease HistoryDetailsSummary
  The Italian Competition Authority Fines a Pharmaceutical Company for Having "Artificially Differentiated" Their Medicinal Products in Breach of Article 101 TFEU (Roche- Novartis/Farmaci Avastin e Lucentis)

Lembo, S., & Matarazzi, G. (2014). The Italian Competition Authority Fines a Pharmaceutical Company for Having "Artificially Differentiated" Their Medicinal Products in Breach of Article 101 TFEU (Roche- Novartis/Farmaci Avastin e Lucentis). Bulletin e-Competitions, 68802.

Item is

 

show all hide all

Basic

show hide
Item Permalink: https://hdl.handle.net/21.11116/0000-000A-15C1-4 Version Permalink: https://hdl.handle.net/21.11116/0000-000A-15C2-3
Genre: Journal Article

Files

show Files

Creators

show
hide
 Creators:
Lembo, Sara1, Author
Matarazzi, Giulio1, Author           
Affiliations:
1External Organizations, ou_persistent22              

Content

show
hide
Free keywords: Italy ; Anticompetitive practices ; Agreement (notion) ; Sanctions / Fines / Penalties ; High market shares ; Pharmaceutical
 Abstract: -

Details

show
hide
Language(s): eng - English
 Dates: 2014-02-27
 Publication Status: Published online
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Bulletin e-Competitions
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: - Sequence Number: 68802 Start / End Page: - Identifier: -